Gus McCubbing

Strategist Matthew Brooks has produced a list of potential M&A targets including Ramsay Health Care, Premier Investments, and Endeavour.

Shares dip; KPMG says ASX ‘zombie’ stocks vanishing; Coles trumps Woolworths in sales; Ampol refinery margins spike; James Hardie chair defiant. Follow live.

Shares rally; Nuix tanks; PolyNovo gains after chairman resigns; Ramelius falls; sliding tobacco sales weigh on Viva’s earnings. Follow live.

From retail champions like JB Hi-Fi and Eagers that are set to gain from falling rates to metal detector maker Codan, fund managers offer their next winners.

Shares down after gold plummets; Woodside ups production forecast; Pinnacle to acquire stake in Japanese fund. Follow live.

From DroneShield to Mineral Resources, smaller investors contributed to a surge in trading activity in the September quarter. But fund managers warn they are buying at the top of the market.

The months-long surge in technology stocks is making it difficult to find prospects. But fund managers say there are good buys from fintech to medical devices.

Shares dip; RBNZ drops rates to 2.5pc in jumbo cut; gold breaks through $US4000 per ounce barrier; Apiam fires after Adamantem completes due diligence. Follow live.

The price of silver has been on a rampage in 2025, rising 55 per cent to eclipse even the whopping rally in gold, as both gain from safe-haven buying.

Fund manager Suhas Nayak used the earnings season to top up some of the more downtrodden stocks in the portfolio including Woolworths and Amcor.

Morningstar says the fair value for some ASX energy stocks is more than double their current share price, despite Ukraine’s hits on Russian oil infrastructure.

Shares down; iron ore surges past $US107; Alcoa to help fund long-stalled WA gas project; BHP settles class action for $110m; gold resets record. Follow updates live.

The long-short fund beat the ASX 200 by nearly 6 per cent in August after it bet against the plasma giant.

The high-profile hedge fund sold down its stake in CSL before the pharmaceuticals giant’s share price plunge while buying up JB Hi-Fi and SGH.

Shares rose; Domino’s recovers after chairman buys $5m of shares; Austal jumps on contract progress; Iress gains 7pc after naming new CEO. Follow updates live.

Australian shares plummet; gold stocks surge; Westpac falls on UBS downgrade; former SA premier buys $30,000 of Medibank shares. Follow updates live.

UBS upgraded prices by up to 32 per cent on expectations for broader and deeper Chinese supply challenges in the coming year.

The rising price of spodumene has triggered a burst of unwinding of negative bets in the lithium sector including Liontown and Mineral Resources.

Life360 has been named the standout of the August earning season, but some fund managers and analysts are warning its blistering rally may run out of puff.

UBS has named seven blue chips stocks that are at risk of being sold during reporting season after stagnant earnings growth, following the same fate as CBA and JB Hi-Fi.